Showing posts with label Microbiology. Show all posts
Showing posts with label Microbiology. Show all posts

Sunday, 6 September 2026

Trachoma eliminated in Timor-Leste.

The elimination of Trachoma, a transmissible Bacterial disease which is thew world's leading infectious cause of blindness, in Timor-Leste (East Timor) has been confirmed by the World Health Organization, according to a press release issued on 3 September 2026. This conformation also marks the elimination of Trachoma across the Southeast Asia Region, with all other countries in that region either having previously eliminated the disease or never having suffered from it. The conformation is therefore a significant step on the way to the World Health Organization's goal of eliminating the disease worldwide by 2030.

The flag of Timor-Leste. Isabel Nolasco/Wikimedia Commons.

The announcement is the result of a campaign of screening which began on Atauro Island in 2015, and which has been rolled out to every region of the country. In 2025, a total of 4949 children aged 0-5 in all 13 municipalities of Timor-Leste did not find a single case of Trachoma, leading to the conclusion that the disease had been eliminated. The country does, however, plan to continue to monitor for Trachoma, and retain the ability to treat the disease.

Trachoma is caused by the Bacterium Chlamydia trachomatis, and spread through contact with mucus emitted from the eyes and nose during infection, and can be spread by Flies. Infections are most common among children, and the disease can spread rapidly in overcrowded environments, particularly where sanitation is poor and access to clean water is limited. The Bacterium infects the inside of the eyelid, causing a roughening which can in turn lead to damage to the surface of the eye. Eventually the disease can lead to the eyelids turning inwards, blinding the patient. Infections are generally fought off fairly quickly, particularly in adults, but having been infected does not offer protection against future infections, and the damage caused by each infection is cumulative. Chlamydia trachomatis is vulnerable to the antibiotics azithromycin and tetracycline.

McCoy cell monolayer micrograph reveals a number of intracellular Chlamydia trachomatis inclusion bodies; Magnified 200 times. The intracellular inclusion body represents the replication phase of the Chlamydia spp. organisms, whereupon, the reorganised reticulate body multiplies through binary fission into 100-500 new reticulate bodies, which mature into elementary bodies. Eugene Arum/Norman Jacobs/Centers for Disease Control and Prevention/Wikimedia Commons.

Timor-Leste is the 33rd country to eliminate Trachoma as a public health risk, with the other countries being Algeria, Australia, Benin, Burundi, Cambodia, China, Egypt, El Salvador, Fiji, The Gambia, Ghana, India, Iraq, Iran, Laos, Libya, Malawi, Mali, Mauritania, Mexico, Morocco, Myanmar, Nepal, Oman, Pakistan, Papua New Guinea, Saudi Arabia, Senegal, Togo, Tunisia, Vanuatu and Vietnam. Trachoma is one of twenty Neglected Tropical Diseases identified by the World Health Organization's Road Map for Neglected Tropical Diseases 2021–2030, with 68 countries now having eliminated at least one of these diseases. 

See also...

Monday, 25 May 2026

Outbreak of Bundibugyo Virus in eastern Democratic Republic of Congo suspected of killing more than 220 people.

More than 220 people are thought to have died, and more than 900 people to have been infected, in an outbreak of Bundibugyo Virus in the Eastern Democratic Republic of Congo, according to a press release issued by the United Nations on 25 May 2025. Bundibugyo Virus, properly Bundibugyo ebolavirus, is a member of the Ebola Virus Family, Filoviridae, which causes an Ebola-like hemorrhagic fever, and is often referred to simply as 'Ebola'.

The World Health Organization was first notified of the outbreak on 5 May 2026, as an unknown illness with a high mortality rate which had already claimed the lives of four health workers in the Mongbwalu Health Zone of Ituri Province, Democratic Republic of Congo. The identity of the disease as Bundibugyo Virus was determined from samples sent to the Institut national de recherche biomédicale in Kinshasa on 15 May. 

By this time the Virus had spread to the Rwampara and Bunia health zones, also in Ituri Province, with 246 reported cases and 80 fatalities. Health workers began investigating clusters of deaths with compatible symptoms in the community. A case was also confirmed in Uganda, after an elderly man from Democratic Republic of Congo was admitted to a private hospital with severe symptoms and subsequently died. This patient was subsequently confirmed as having been infected with Bundibugyo Virus by the Central Emergency Surveillance and Response Support Laboratory at Wandegeya. His remains were subsequently returned to the Democratic Republic of Congo. A second case was reported in Uganda on 16 May, this time a Ugandan national who had recently returned from Democratic Republic of Congo. This patient is being treated in Uganda; no transmission of the Virus in Uganda has been reported. 

Health Zones affected by Bundibugyo Virus Disease in Democratic Republic of Congo, as of 16 May 2026. World Health Organization.

By 21 May the outbreak had spread to North Kivu and South Kivu provinces, with 746 suspected cases and 176 deaths thought to have been caused by Bundibugyo Virus, although only 85 cases, including ten fatalities have been confirmed by laboratory analysis. No further cases had been reported in Uganda, but an American national who had been working as a surgeon in Democratic Republic of Congo was confirmed as having the Virus and airlifted to Germany for treatment.

Risk mapping of Health Zones in Democratic Republic of Congo as of 21 May 2026. World Health Organization.

Bundibugyo Virus was first described in 2008 following an outbreak in Bundibugyo District Uganda. Only one subsequent outbreak has been reported prior to 2026, in Province Orientale, Democratic Republic of Congo, in 2012. Thus, although the Virus is closely related to Ebola, and produces a similar disease, there has been no specific treatment developed for it, and no vaccine to prevent its spread. This has made it difficult to implement an effective treatment and containment program against a disease with a 30% fatality rate.

Ituri Province is located in the northeast of Democratic Republic of Congo, with borders with Uganda and South Sudan. It has a large, if generally informal, mining sector, which attracts workers from neighbouring provinces and countries. The infrastructure of Ituri Province is generally weak, with healthcare services largely dependent on support by aid programs run by western countries, particularly the United States. These programs have been cut heavily by the current US administration, further weakening healthcare provision.

To make matters worse, a long running conflict in the province has seen an upsurge in violence since December 2025, with fighting between the Convention for the Popular Revolution and the Armed Forces of the Democratic Republic of Congo leading to at least 40 people being killed and around 100 000 being displaced. The Convention for the Popular Revolution is one of several rebel groups active in the region, and has been accused by the Congolese Government of forcibly recruiting child soldiers and being a front for the Ugandan and/or Rwandan governments to exploit the regions mineral wealth. Nevertheless, the Convention for the Popular Revolution has sometimes worked alongside the Armed Forces of the Democratic Republic of Congo and Ugandan Army to fight against other groups, notably the Allied Democratic Forces, a group thought to be allied to Islamic State.

Unloading supplies for the isolation and treatment tents at the Bunia Referral Hospital, Ituri Province, Democratic Republic of the Congo, May 2026. World Health Organization.

All of this has made it extremely difficult to implement effective track-and-trace and treatment programs to contain the Bundibugyo Virus outbreak. To complicate things further, a disinformation campaign appears to have been circulating on social media, adding to the distrust of outsiders and officialdom in general which is prevalent in the local population, something that has led to attacks on healthcare workers and facilities. Local people have reportedly set fire to two treatment centres in which patients were being treated in isolation, following a dispute over a safe burials program implemented to prevent the spread of the disease. This involves the burial of the deceased by healthcare workers with a minimal number of people present, and goes against local customs of large funerals and ritually washing the dead by relatives. 

See also...

Sunday, 17 May 2026

Algeria, Australia, and Tunisia have all eliminated Trachoma as a public health risk.

On 23 April 2026 the World Health Organization published a press release confirming that Algeria had eliminated Trachoma, a transmissible Bacterial disease which is thew world's leading infectious cause of blindness. On 29 April a second press release confirmed that Australia had eliminated the disease. On 14 May a third press release confirmed that Trachoma had also been eliminated in Tunisia. This brings the number of countries which have eliminated the once widespread tropical disease to 31. Countries where it has previously been eliminated are: Benin, Burundi, Cambodia, China, Egypt, Fiji, The Gambia, Ghana, India, Iraq, Iran, Laos, Libya, Malawi, Mali, Mauritania, Mexico, Morocco, Myanmar, Nepal, Oman, Pakistan, Papua New Guinea, Saudi Arabia, Senegal, Togo, Vanuatu and Vietnam.

Regular examination of eyes at risk can help to reduce the incidence of communicable diseases such as Trachoma. Lily Solomon/World Health Organization.

Trachoma is caused by the Bacterium Chlamydia trachomatis, and spread through contact with mucus emitted from the eyes and nose during infection, and can be spread by Flies. Infections are most common among children, and the disease can spread rapidly in overcrowded environments, particularly where sanitation is poor and access to clean water is limited. The Bacterium infects the inside of the eyelid, causing a roughening which can in turn lead to damage to the surface of the eye. Eventually the disease can lead to the eyelids turning inwards, blinding the patient. Infections are generally fought off fairly quickly, particularly in adults, but having been infected does not offer protection against future infections, and the damage caused by each infection is cumulative. Chlamydia trachomatis is vulnerable to the antibiotics azithromycin and tetracycline.

McCoy cell monolayer micrograph reveals a number of intracellular Chlamydia trachomatis inclusion bodies; Magnified 200 times. The intracellular inclusion body represents the replication phase of the Chlamydia spp. organisms, whereupon, the reorganised reticulate body multiplies through binary fission into 100-500 new reticulate bodies, which mature into elementary bodies. Eugene Arum/Norman Jacobs/Centers for Disease Control and Prevention/Wikimedia Commons.

All three countries have been waging public health campaigns against Trachoma for many decades, with recent successes in eliminating infections attributed to the adoption of the World Health Organization's 'SAFE' strategy on the disease. This relies on four pillars, Surgery, which is used to save patients sight before it is lost in advances cases, Antibiotics, which are administered en masse during outbreaks, Facial cleanliness, in which large scale public health campaigns promote personal hygeine as a way to stop the spread of the disease, and Environment, in which access to clean water and good sanitation is improved. 

Mural promoting facial cleanliness to eliminate Trachoma, at Warburton in Western Australia. Minum Barreng: Indigenous Eye Health Unit/University of Melbourne/World Health Organization.

Both Algeria and Tunisia have historically had particular problems with Trachoma in their more arid southern provinces, where access to clean water has been limited. It has been estimated that in the early and mid twentieth centuries, as much as half of the population of southern Tunisia may have been affected by the disease.

World Health Organization consultant, Mario Tarizzo, prepares to take an eye smear from a school child at Srendi on the Tunisian island of Djerba. The World Health Organization has supported long-standing efforts in Tunisia to eliminate Trachoma, a disease of the eye that can cause blindness if left untreated. Eric Schwab/World Health Organization.

In Australia Trachoma was eliminated in much of the country decades ago, but has persisted in many remote Aboriginal and Torres Strait Islander communities, where access to both clean water and healthcare facilities can be very limited, and not everyone speaks English as a first language. In recent years bringing healthcare to such communities has been driven by a network of Aboriginal Community Controlled Health Organisations, which are better able to understand the healthcare needs of indigenous Australians, and deliver solutions in a culturally appropriate way.

Trachoma is one of 21 Neglected Tropical Diseases associated with devastating health, social and economic consequences outlined in the Roadmap proposed by the World Health Organization's Executive Board at its 146th session in February 2020, and adopted by the Seventy-third World Health Assembly in November 2020. This Roadmap aims to control, eliminate, or eradicate all of these diseases by 2021, in line with the United Nation's third Sustainable Development Goal: Ensure healthy lives and promote well-being for all at all ages. The elimination of Trachoma in Algeria and Tunisia makes then the 62nd and 63rd countries to have eliminated at least one Neglected Tropical Disease since the adoption of the Roadmap.

See also...

Wednesday, 13 May 2026

Three fatalities in Hantavirus outbreak on Dutch cruise ship.

Three people have died and a further five people have been infected in an outbreak of Hantavirus on the Dutch cruise ship MV Hondius, according to a press release issued by the World Health Organization on 8 May 2026. The disease, which is caused by the Virus Orthohantavirus andesense, is a zoonotic disease (disease with a reserve in a wild Animal population which sometimes spreads to Humans) causing a hemorrhagic or pulmonary fever. It is not easily passed from Human-to-Human, but can do so when people are living together in close conditions in an environment such as a cruise ship.

The outbreak is thought to have begun with an 70-year-old male Dutch national who boarded the ship at Ushuaia, on the Argentinian part of Tierra del Fuego, on 1 April 2026, after spending three months touring Argentina, Chile, and Uruguay. This patient developed symptoms at sea, and died on 11 April before the ship reached any port. He is considered a probable case, as no microbiological tests were carried out. 

The MV Hondius, a 106.7 m Polar Class 6 vessel, designed for luxury touring in polar regions with a minimal environmental impact, which was hit by Hantavirus outbreak in April and May 2026. Oceanwide Expeditions.

The second patient to develop the disease was the original patient's 69-year-old widow, who had been travelling with the first patient and joined the ship with him. She developed gastrointestinal symptoms at sea, and left the ship when it arrived at Saint Helena on 24 April, and flew to Johannesburg the following day, where she boarded a flight to Amsterdam, where her condition deteriorated rapidly, causing her to be removed from the plane and moved to a local hospital, where she died on 26 April. She was confirmed as being infected with Orthohantavirus andesense by polymerise chain reaction testing carried out by the South African National Institute for Communicable Diseases.

The third patient, another adult male, started to show symptoms on 24 April, and was evacuated from the ship when it put into Ascension Island on 27 April. This patient was also airlifted to Johannesburg, where he is being treated in an intensive care unit. This patient was also confirmed as being infected with Orthohantavirus andesense by polymerise chain reaction testing.

A fourth patient, and adult female German national, developed a fever on 28 April, while the ship was sailing between Ascension Island and the Cape Verde islands, and died of pneumonia on 2 May, before the ship made it to port. This patient was later confirmed to have died of Hantavirus by post-mortem examination.

The fifth patient, the ship's doctor, began to develop symptoms on 30 April, and was confirmed as having Hantavirus by polymerise chain reaction testing when the ship reached Cape Verde on 6 May, and was airlifted to the Netherlands, where he is currently being treated in an isolation unit. 

The sixth patient, a guide employed on the ship, reported mild respiratory and gastrointestinal symptoms on 27 April. He was also diagnosed with Hantavirus infection by polymerise chain reaction testing when the ship reached Cape Verde and airlifted to the Netherlands.

A seventh patient, who disembarked from the ship at St Helena on 22 April and flew home to Switzerland via South Africa and Qatar, began to show symptoms on 1 May. He immediately self-reported to medical authorities in Switzerland, and is now being treated in an isolation unit there.

An eighth patient, who disembarked from the ship at Tristan da Cunha in the South Atlantic on 14 April, began to show symptoms on 28 April. He is now being treated in isolation, although results of testing for the Virus have yet to be returned.

A ninth patient with Hantavirus-like symptoms was evacuated at Cape Verde and airlifted to Germany, but was later found not to be infected.  Efforts are still being made to trace 32 other patients who disembarked at Saint Helena and dispersed to a variety of countries before the nature of the outbreak was understood. After leaving Cape Verde the ship sailed to the Canary Islands, where it was met by medical personnel from the World Health Organization and a variety of countries, where both passengers and crew were screened for the Virus before being allowed to travel on to their home countries, where they will be required to undergo a period of isolation. A skeleton crew and medical personnel remained on the ship while it was sailed to the Netherlands to be thoroughly disinfected. 

Stops made by the MV Hondius during the outbreak. On 11 May, the ship was en route to Rotterdam. Wikipedia.

A flight attendant on the Johannesburg-Amsterdam flight from which the second patient was removed also later developed symptoms, and was admitted to a hospital in Amsterdam. Two Singaporean nationals who had been on the ship and subsequent flight from Saint Helena to Johannesburg were tested for the Virus after one developed Hantavirus-like symptoms, but neither was found to be infected. Attempts are still being made to trace passengers from both fights.

Hantavirus infections are caused by triple single-stranded negative-sense RNA Viruses of the genus Orthohantavirus. These Viruses are typically found in Rodents, with 28 species known, each of which infects a different species of Rodent. These Viruses occasionally jump species and infect Humans, where they break down into two groups, Old World Hantaviruses, which can cause a hemorrhagic fever accompanied by a severe kidney infection, and New World Hantaviruses, which cause a severe respiratory disease.


Structure of the Andes Hantavirus. Lexi Schoonover/Hope College/Wikimedia Commons.

The Andes Hantavirus, Orthohantavirus andesense, is found in Long-tailed Pygmy Rice Rats, Oligoryzomys longicaudatus, a wild Rodent found in the southern Andes of Chile and Argentina, where it does not appear to produce any symptoms. It can be transmitted to Humans through the inhalation of  aerosols that contain rodent saliva, urine, or feces, through the consumption of contaminated food, or by being bitten or scratched by a Rat.

A Long-tailed Pygmy Rice Rat, Oligoryzomys longicaudatus, the wild vector of the Andes Hantavirus. Yamil Hussain/Wikimedia Commons.

There is no effective treatment or vaccine for Hantavirus, and the disease is best prevented by using cleanliness and good hygiene to keep Rodents from entering Human dwellings or workplaces. If this fails a pest control consultant should be used to remove the Rodents. Placing infected patients in intensive care with fluids and, if necessary, artificial respiration, can help, but even with these precautions about 30% of patients typically die. Patients who have been infected with the disease and survive are generally immune to further infections with the same Virus.

See also...